PNPO anticorps
Aperçu rapide pour PNPO anticorps (ABIN7248506)
Antigène
Voir toutes PNPO AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Antigen affinity purification
-
Immunogène
- Synthetic peptide of human PNPO
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000, IHC 1:20-1:100, ELISA 1:5000-1:10000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.9 mg/mL
-
Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- PNPO (Pyridoxamine 5'-Phosphate Oxidase (PNPO))
-
Autre désignation
- PNPO
-
Sujet
- The enzyme encoded by this gene catalyzes the terminal, rate-limiting step in the synthesis of pyridoxal 5'-phosphate, also known as vitamin B6. Vitamin B6 is a required co-factor for enzymes involved in both homocysteine metabolism and synthesis of neurotransmitters such as catecholamine. Mutations in this gene result in pyridoxamine 5'-phosphate oxidase (PNPO) deficiency, a form of neonatal epileptic encephalopathy.
-
Poids moléculaire
-
Observed_MW: Refer to figures
Calculated_MW: 30 kDa
-
UniProt
- Q9NVS9
Antigène
-